Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55.4M
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
48.3M
-
Shares change
-
-3.48M
-
Total reported value, excl. options
-
$58.9M
-
Value change
-
-$6.03M
-
Put/Call ratio
-
0.27
-
Number of buys
-
11
-
Number of sells
-
-32
-
Price
-
$1.22
Significant Holders of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) as of Q3 2024
74 filings reported holding OMGAQ - Omega Therapeutics, Inc. - COMMON STOCK as of Q3 2024.
Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.3M shares
of 55.4M outstanding shares and own 87.24% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (29.2M shares), FMR LLC (6.06M shares), HarbourVest Partners LLC (3.51M shares), STATE OF WISCONSIN INVESTMENT BOARD (1.86M shares), Siren, L.L.C. (1.32M shares), VANGUARD GROUP INC (1.11M shares), Blue Owl Capital Holdings LP (1.06M shares), 683 Capital Management, LLC (600K shares), MILLENNIUM MANAGEMENT LLC (536K shares), and RENAISSANCE TECHNOLOGIES LLC (475K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.